ArticleFrontiers in cellular and infection microbiology2025
Bloodstream infection with NDM-1/5
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Molecular epidemiology and antimicrobial resistance of extended-spectrum beta-lactamases-producingJAC-antimicrobial resistance · 2026Article
- Plasmid-resolved genomics and machine learning-assisted profiling revealFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To elucidate the molecular epidemiology, virulence repertoire and resistance gene characteristics of carbapenem-resistant Methods: We retrospectively collected 13 non-replicate CRECC-BSI isolates from January 2019 to December 2023 at a tertiary-care hospital in Shandong Province, China. Antimicrobial susceptibility was determined by broth microdilution; Illumina NovaSeq whole-genome sequencing was performed, and genomes were assembled with ABySS and GapCloser. ResFinder, VFDB, CGE and NCBI Pathogen Detection databases were used jointly to analyze resistance genes, virulence factors, plasmid replicons, MLST an SNP-based phylogenetic tree assessed inter-strain relatedness; while filter-mating assays determined the transferability of plasmids. Results: A total of 13 CRECC isolates yielded five sequence types (STs), with ST171 predominating (46.2%, 6/13); all carried Conclusions: Our institutional CRECC-BSI is characterized by diverse sequence types, a complex plasmid profile and a high burden of virulence genes; ST171 is the dominant clone and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.